Pharmuna raises $5M to expand AI pharmacy platform

Pharmuna has raised $5 million through FasterCapital, with CEO Hesham Zreik serving as lead investor, to scale its AI-powered pharmacy guidance platform and expand into new markets. The San Jose startup plans to grow its healthcare professional network, improve medication support, and add safeguards that steer users to licensed care when needed.

Why it matters: - Pharmuna is building an AI-first entry point for common medication and healthcare questions. - The platform is designed to help users get clearer guidance faster, while still directing them to pharmacists, doctors and other professionals when a case needs human judgment. - The new funding supports product development and international expansion at a time when consumers increasingly search online for health information, often with mixed-quality results.

What happened: - Pharmuna raised $5 million through FasterCapital. - Hesham Zreik, CEO of FasterCapital, personally invested and is serving as lead investor. - FasterCapital led the round, and multiple venture capital investors participated. - Pharmuna previously secured $200,000 to support its initial development and growth. - The company is based in San Jose, California.

The details: - Pharmuna uses artificial intelligence to provide immediate, easy-to-understand preliminary guidance about medications and general healthcare concerns. - The platform helps users understand medicine-related information, identify questions to raise with healthcare professionals and recognize when professional medical advice is needed. - Pharmuna is designed to support, not replace, doctors, pharmacists and other healthcare professionals. - When users need specialized help, the platform is intended to connect them with qualified pharmacists, doctors and other healthcare providers. - FasterCapital is also supporting Pharmuna through its fundraising and venture-building programs. - The support includes fundraising preparation, investor outreach, business development, product strategy, international expansion and strategic advisory. - With the new funding, Pharmuna plans to strengthen its AI capabilities, expand its healthcare professional network, improve pharmacy and medication guidance services and reach users in additional markets. - Pharmuna also plans to enhance medication and drug-interaction information, improve user experience and develop safeguards and escalation mechanisms for cases that require individualized diagnosis or treatment. - FasterCapital says it will use its investor network and venture-building resources to help Pharmuna connect with more investors and strategic partners as the round progresses. - Zreik said the investment reflects the need for faster access to healthcare information, paired with the judgment of qualified professionals. - Zreik also said FasterCapital will support the team across fundraising, product development, market expansion, investor readiness and strategic growth.

Between the lines: - Pharmuna is trying to solve a common gap between self-service health information and professional medical care. - The pitch is not just about faster answers. It is about using AI to sort routine questions from situations that need human expertise. - The company’s strategy suggests a hybrid model: software for first-pass guidance and a broader network of clinicians for escalation. - FasterCapital’s role goes beyond capital and includes incubation-style support, which may help Pharmuna move faster on product and market expansion.

What’s next: - Pharmuna will continue developing its AI-powered guidance technology. - The company plans to expand its network of healthcare professionals and pharmacies. - Pharmuna will work to enter additional international markets. - FasterCapital will continue supporting the company as it finishes the $5 million fundraising effort and seeks additional investors and partners. - The company is also expected to keep building safety features that route users to professional care when needed.

The bottom line: - Pharmuna is betting that the next wave of consumer health tools will combine AI convenience with direct access to licensed care.